Cargando…
Molecular Markers of Pediatric Solid Tumors—Diagnosis, Optimizing Treatments, and Determining Susceptibility: Current State and Future Directions
Advances in molecular technologies, from genomics and transcriptomics to epigenetics, are providing unprecedented insight into the molecular landscape of pediatric tumors. Multi-omics approaches provide an opportunity to identify a wide spectrum of molecular alterations that account for the initiati...
Autores principales: | Trubicka, Joanna, Grajkowska, Wiesława, Dembowska-Bagińska, Bożenna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997439/ https://www.ncbi.nlm.nih.gov/pubmed/35406801 http://dx.doi.org/10.3390/cells11071238 |
Ejemplares similares
-
HGG-21. GERMLINE MUTATIONS IN MSH2 GENE IN PEDIATRIC PATIENTS WITH CONGENITAL AND SPORADIC GLIOBLASTOMA
por: Ejmont, Maria, et al.
Publicado: (2020) -
OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas
por: Kaleta, Magdalena, et al.
Publicado: (2019) -
HGG-23. The presence ofROS1 fusions are not limited only to infantile hemispheric glioma.
por: Trubicka, Joanna, et al.
Publicado: (2022) -
Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors
por: Łastowska, Maria, et al.
Publicado: (2018) -
The germline variants in DNA repair genes in pediatric medulloblastoma: a challenge for current therapeutic strategies
por: Trubicka, Joanna, et al.
Publicado: (2017)